We have published revised versions of the OMRON Privacy Policy and Cookie Policy. Your use of our products and services is subject to these revised terms.

This website uses cookies. By continuing to browse through this website, you agree to our Cookie Policy which has been revised in May 2018.

Allow cookies
OMRON nebulizer for bronchitis


Bronchitis is a disease which involves an inflammation of bronchial tubes that carry the air to and from the lungs. The inflammation causes a cough with mucus.

What is bronchitis?

Bronchitis is defined as a condition which involves an inflammation of bronchial tubes that carry the air to and from the alveoli (the lowest part of the lungs which plays a role in exchanging oxygen). The inflammation causes thick mucus to form in the bronchial tubes and to be brought up with a cough. Bronchitis usually occurs following the flu or a common cold and bronchitis is more common in children of older age and adults. Bronchitis should not be confused with bronchiolitis, which is more common in babies.

There are two types of bronchitis, including acute bronchitis and chronic bronchitis.

Acute bronchitis occurs as a result of viral infections or lung irritants, and sometimes it can be caused by bacteria, too. Acute bronchitis usually lasts about 10 days.

Chronic bronchitis is a long-term serious condition which occurs when the lining of the bronchial tubes is constantly irritated and inflamed. Symptoms of chronic bronchitis worsen over time and last for at least 3 months.


The main acute bronchitis symptom is a persistent cough with mucus. Other symptoms of acute bronchitis are similar to those of a common cold, including sore throat, wheezing, fatigue, shortness of breath, low-grade fever, and chest tightness. These symptoms normally last for a few weeks.

The symptoms of chronic bronchitis are very similar to acute bronchitis symptoms but they are more severe and can last from three months to years.

Causes and risk factors

The main cause of bronchitis is a viral infection. Several other types of viruses, including those that cause the flu and a common cold, can also be a bronchitis cause.

Major bronchitis risk factors include smoking tobacco, exposure to lung irritants, being diagnosed with gastroesophageal reflux disease (GERD) and having a weakened immune systems.

  • Tobacco smoke: Tobacco has a substantial dose of carcinogens and toxins. A smoker as well as people who inhale second-hand smoke are at higher risk of bronchitis than who do not.
  • Exposure to lung irritants: These irritants such as grains, textiles and chemical fumes whether in the living or working environment is also a risk factor for bronchitis.
  • Gastroesophageal reflux disease (GERD): People with underlying GERD, also known as acid reflux and gastric reflux, are at risk of developing bronchitis. Repeated bouts of severe heartburn can irritate the throat and cause it to become inflamed.
  • Weakened immune systems: An acute illness like a cold can temporarily cause lower resistance in the immune system than usual. During or after a cold, the patient is thus likely to develop bronchitis. Children whose resistance to viruses is generally low are also placed at risk of developing bronchitis.


Treatment for both types of bronchitis is meant to relieve the symptoms and ease the breathing.

To treat acute bronchitis, rest, plenty of fluids, and aspirin (for adults) or acetaminophen are recommended. Antibiotics are usually not prescribed for treating bronchitis unless the cause is a bacterial infection. If wheezing is present with the disease, inhaled medicines may be described. Inhaled medicines can be delivered to the lungs using an inhaler or a nebulizer. A nebulizer is recommended for treating bronchitis in elderly people, infants, and young children, because their age-related weakness in muscles or tremor (shaking of muscles) can cause difficulties using an inhaler.

Chronic bronchitis treatment options are similar to those for chronic obstructive pulmonary disease (COPD), including taking a combination of medicines like inhaled bronchodilators and inhaled steroids with the use of a nebulizer, and receiving oxygen therapy.


  1. Bateman, E., Hurd, S., Barnes, P., Bousquet, J., Drazen, J., FitzGerald, M., . . . Zar, H. (2008). Global strategy for asthma management and prevention: GINA executive summary. European Respiratory Journal, 31(1), 143-178. Retrieved from http://erj.ersjournals.com/content/erj/31/1/143.full.pdf
  2. Mayo Foundation for Medical Education and Research. (2014, April 4). Risk factors. Retrieved from Mayo Clinic: http://www.mayoclinic.org/diseases-conditions/bronchitis/basics/risk-factors/con-20014956
  3. National Health Service. (2016, August 3). Bronchitis. Retrieved from NHS Choices: http://www.nhs.uk/Conditions/Bronchitis/Pages/Introduction.aspx
  4. National Institutes of Health. (2011, August 4). How is bronchitis treated? Retrieved from National Heart, Lung and Blood Institute: https://www.nhlbi.nih.gov/health/health-topics/topics/brnchi/treatment
  5. National Institutes of Health. (2011, August 4). What is bronchitis? Retrieved from National Heart, Lung and Blood Institute: https://www.nhlbi.nih.gov/health/health-topics/topics/brnchi